Metrion and Grünenthal extend Ion Channel Research Agreement

2020-11-06T10:11:31+00:00

Introduction Metrion Biosciences have had a longstanding relationship providing drug discovery research services to Grünenthal GmbH, a privately owned pharmaceutical company and global leader in pain management and related diseases. Grünenthal develop medication for patients with severe and debilitating diseases and high unmet medical needs and have a long track record of bringing innovative [...]